Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

720
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
720
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

619
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
619
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Hypoxia01:23

Hypoxia

2.5K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung Imaging in Acute Hypoxemic Respiratory Failure: From Physics to Bedside Applications.

Journal of clinical medicine·2026
Same author

Tracking the energetics of mechanical ventilation: real-time patient-ventilator interaction.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Acid-base balance and respiratory mechanics during robotic-assisted surgery: an observational study.

Journal of robotic surgery·2026
Same author

Defining the Resolution of Acute Respiratory Distress Syndrome: A Missing Piece in Critical Care.

Critical care medicine·2026
Same author

Effects of High-Flow Nasal Cannula and Helmet Continuous Positive Airway Pressure in Acute Hypoxemic Respiratory Failure.

Critical care medicine·2026
Same author

The invasive and non-invasive monitoring of inspiratory effort and drive during assisted mechanical ventilation.

Annals of intensive care·2026

Related Experiment Video

Updated: Mar 20, 2026

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

14.9K

Severe hypoxemia: which strategy to choose.

Davide Chiumello1,2, Matteo Brioni3

  • 1Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Via F. Sforza 35, Milan, Italy. chiumello@libero.it.

Critical Care (London, England)
|June 4, 2016
PubMed
Summary

Severe acute respiratory distress syndrome (ARDS) requires tailored mechanical ventilation and adjuvant therapies like prone positioning to improve oxygenation and reduce mortality. Early consideration of neuromuscular blocking agents and extracorporeal membrane oxygenation may benefit critically ill patients.

More Related Videos

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
07:15

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Published on: December 5, 2025

558
Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
08:51

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model

Published on: November 11, 2022

2.1K

Related Experiment Videos

Last Updated: Mar 20, 2026

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

14.9K
Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
07:15

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Published on: December 5, 2025

558
Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
08:51

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model

Published on: November 11, 2022

2.1K

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Respiratory Physiology

Background:

  • Acute respiratory distress syndrome (ARDS) is a severe condition characterized by pulmonary edema and refractory hypoxemia.
  • Severe ARDS, defined by PaO2/FiO2 < 100 mmHg, affects 20-30% of patients and has the highest mortality rate.
  • Standard treatment involves mechanical ventilation, but adjuvant therapies are explored for severe hypoxemia.

Purpose of the Study:

  • To review current clinical strategies for managing severe hypoxemia in ARDS patients.
  • To evaluate the efficacy and risks of various adjuvant therapies.
  • To provide an up-to-date overview of ARDS management.

Main Methods:

  • Clinical review of available strategies for ARDS patients with severe hypoxemia.
  • Analysis of data regarding mechanical ventilation settings and adjuvant therapies.
  • Evaluation of risk-benefit profiles for different interventions.

Main Results:

  • Noninvasive ventilation has a high failure risk in moderate-to-severe ARDS; delayed mechanical ventilation requires careful risk-benefit assessment.
  • Individualized mechanical ventilation, including low tidal volume and optimized positive end-expiratory pressure, is crucial to prevent VILI.
  • Prone positioning, neuromuscular blocking agents (NMBAs), and extracorporeal membrane oxygenation (ECMO) can improve outcomes in severe ARDS, particularly when applied early.

Conclusions:

  • Severe ARDS management necessitates a comprehensive approach combining respiratory and hemodynamic support.
  • Protective mechanical ventilation, lung recruitment, and tailored strategies are essential to minimize VILI.
  • NMBAs, prone positioning, and ECMO are valuable considerations for the most severe ARDS cases.